Mark Czeterko

Title: Mark Czeterko: Innovator in Cell Culture Technology

Introduction

Mark Czeterko is a notable inventor based in Stamford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell culture technology. With a total of 2 patents, his work focuses on improving methods for large-scale production of proteins and polypeptides.

Latest Patents

Czeterko's latest patent, titled "Metabolically Optimized Cell Culture," presents improved methods for large-scale production of proteins and/or polypeptides in cell culture. This innovative method allows for the culturing of cells that have metabolically shifted, enabling high levels of protein or polypeptide production while reducing the accumulation of unwanted metabolic waste, such as lactate. The proteins and polypeptides produced through this method can be utilized in the preparation of pharmaceutical, immunogenic, or other commercial biologic compositions, including antibodies.

Career Highlights

Mark Czeterko is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency and effectiveness of protein production processes.

Collaborations

Some of his notable coworkers include Shawn M Lawrence and Michelle LaFond, who contribute to the collaborative environment at Regeneron Pharmaceuticals.

Conclusion

Mark Czeterko's innovative work in cell culture technology has the potential to significantly impact the biotechnology industry. His patents reflect a commitment to advancing methods that improve protein production, which is crucial for various applications in medicine and biotechnology.